Calcium sulphate/hydroxyapatite composite periodontal cement dressing loaded with doxycycline for localised drug delivery: Mechanical, radiographical, and antimicrobial insights

Abstract

This study developed and evaluated calcium sulphate/hydroxyapatite (CS/HAp)-based periodontal cement dressings incorporating doxycycline (DOX) as a localized drug delivery system. Characterisation via SEM, FTIR, XRD, and radiographic imaging revealed that while the manufacturing process and powder packing yielded relatively uniform total porosities across all formulations (~26–42% surface; ~30–36% bulk), composition strongly dictated the material's performance. Radiopacity progressively increased with higher HAp content due to greater X-ray attenuation from calcium-rich phases. Mechanical testing demonstrated that the mixed-phase compositions significantly enhanced load-bearing capacity compared to single-component materials. Specifically, the S 1.5 H 0.5 formulation exhibited the highest break force, indicating superior load-bearing capacity, driven by the chemical cementing effect of calcium sulphate reacting with potassium sulphate, whilst displaying a ductile, elastic–plastic deformation behaviour via progressive pore collapse. The composites exhibited gradual in vitro degradation behaviour, excellent radiopacity, drug release profile characterized by a relatively rapid initial release followed by a slower and more gradual release phase, while inhibiting Staphylococcus aureus and Escherichia coli in vitro . Among the formulations, the S 1.5 H 0.5 composition demonstrated the optimum balance of mechanical properties, structural uniformity, and drug release behaviour, highlighting its strong potential for clinical dental and periodontal applications.

Access to Document

Other files and links

• Link to publication in Scopus
• Open Access Version Available

Fingerprint